Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe top stories
genentech
life sciences
national blog main
national top stories
novartis
2
×
roche
2
×
san francisco top stories
avapritinib
billy dunn
biogen
blueprint medicines
boston
boston blog main
boston top stories
cancer
cancer drugs
capmatinib
clinical trials
drug prices
drug pricing
eli lilly
europe blog main
evrysdi
fda
gastrointestinal stromal tumors
gene therapy
indiana blog main
indiana top stories
ionis pharmaceuticals
life science
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
nusinersen
pralsetinib
risdiplam
rna drugs
What
drug
fda
2
×
therapy
address
approval
approved
approves
atrophy
blueprint
cancer
carries
certain
daily
designed
evrysdi
friday
genetic
green
home
intended
latest
lights
liquid
medicine
medicines
muscular
new
oral
pass
patients
ret
risdiplam
roche
signature
signatures
spinal
targeted
targeting
Language
unset
Current search:
novartis
×
fda
×
roche
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy